BRKR250117C45000
- 6.20
- 0.000.00%
Bruker Corp Newsroom
S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead
Bruker to Seek Injunction, Appeal After Court Sides With 10x Genomics in Patent Dispute
Bruker Plans to File for a Stay of NanoString GeoMX Injunction Ruling
Express News | Bruker Corp: Expect to Promptly Seek a Stay of Any Injunction That Is Finally Ordered
Express News | Bruker Corp: Disagree With District Court's Decision to Grant Injunction With Respect to Sales of Geomx Products to New Customers in United States
Bruker Comments on Delaware District Court's Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products
10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US
10x Genomics: Injunction Expected to Prohibit Bruker From Making, Using, Selling or Offering to Sell in U.S. GeoMx Digital Spatial Profiler and Associated Instruments, Reagents and Services for RNA and Protein Detection >BRKR
Reported Earlier, Delaware Jury Awards 10x Genomics $31.7M In Patent Case Against NanoString; Permanent Injunction On GeoMx Takes Effect January 10, 2025, With Royalties For Existing Installations; Additional Rulings On CosMx Expected Spring 2025
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs
Guggenheim Initiates Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $72
Bruker Reveals 1.2 GHz NMR Spectrometer At Swiss High-field NMR Facility
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
Bruker Initiated at Buy by Guggenheim
Express News | Bruker Corp : Guggenheim Initiates Coverage With Buy Rating; Target Price $72
Unusual Options Activity: BRKR, TSLA and Others Attract Market Bets, BRKR V/OI Ratio Reaches 250.0
Bruker (NASDAQ:BRKR) Shareholders Have Endured a 26% Loss From Investing in the Stock Three Years Ago
Unusual Options Activity: PINS, BRKR and Others Attract Market Bets, PINS V/OI Ratio Reaches 892.9
Bruker Is Maintained at Buy by B of A Securities
Express News | Bruker Corp : BofA Global Research Raises Price Objective to $80 From $78